Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
December 5, 2023
Skye Bioscience Treats First Patient in Glaucoma Phase 2 Study of SBI-100 Ophthalmic Emulsion
December 5, 2023
Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer
December 5, 2023
Inipharm Initiates Dosing in Phase 1 Study of Its Small Molecule Inhibitor of HSD17B13
November 29, 2023
Data Demonstrating Precede Biosciences Ability to Determine HER2 Status from 1mL of Plasma to be Presented at the 2023 San Antonio Breast Cancer Symposium
November 29, 2023
Escient Pharmaceuticals Initiates Clinical Proof-of-Concept Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist, in Atopic Dermatitis
November 28, 2023
HALIO, the Industry’s Leader in Smart Glass Technology, Raises $70M from Korea’s SKC to Impact the Environment and Energy Savings
November 28, 2023
Rallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia
November 16, 2023
Q32 Bio and Homology Medicines Announce Merger Agreement
November 14, 2023
Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
November 13, 2023
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
« Previous Page
1
…
3
4
5
6
7
…
119
Next Page »